HAIFA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial ...
New U.S. intellectual property protections expand use of Minovia’s leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseasesHAIFA, Israel, Jan. 13, 2026 ...
SICK AG and its affiliates were hit with a patent infringement lawsuit on Nov. 2 in Texas Southern District Court over their SICK Visionary-S 3D vision sensors products. The action, brought by ...
The AI patent enhances video and image processing, enabling efficient media data acquisition, feature identification, and dynamic augmentation during playback. We are excited to include this new ...
Various power augmentation methods have emerged in recent years to enable gas turbine owners to recover some of the power that is lost as ambient air temperatures rise. Extensive analyses conducted by ...
New U.S. intellectual property protections expand use of Minovia’s leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases HAIFA, Israel, Jan. 13, 2026 ...
Vision Augmentation Technology was slapped with a patent lawsuit on Oct. 30 in Minnesota District Court. The lawsuit, brought by Fish & Richardson on behalf of three Sick Inc. companies, seeks a ...
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition PRESS RELEASE GlobeNewswire Nov. 20, 2025, 08:30 AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results